Resident, Department of Oral and Maxillofacial Surgery, University of Tennessee Medical Center, Knoxville, TN.
Assistant Professor, Department of Surgery- Division of Plastic, Maxillofacial, and Oral Surgery, Department of Head and Neck Surgery & Communication Sciences, Duke University Medical Center, Durham, NC.
J Oral Maxillofac Surg. 2021 Jun;79(6):1355-1363. doi: 10.1016/j.joms.2020.12.021. Epub 2021 Jan 16.
Inadequate nutrition is common in individuals diagnosed with cancer. The present study evaluated the association between preoperative albumin and postoperative complications in otherwise healthy patients presenting with newly diagnosed squamous cell carcinoma of the oral cavity primarily managed with ablative surgery.
A retrospective cohort study of patients with newly diagnosed oral squamous cell carcinoma from 2005 to 2019 was performed. Patients referred to and managed by a single surgeon (ERC) and who had not received any nutritional support in the preoperative period were included in the study. The primary predictor variable was preoperative albumin level. Other studied variables were patient demographic data and TNM stage. Complications related to primary ablative surgery represented the primary outcome variable. χ analysis was completed to assess for significant associations between independent albumin groups (4+, 3.5 to 3.9, and 3.0 to 3.4 g/dL) in relation to postoperative complications. Multivariate logistic regression analysis was completed to control for clinical variables and medical comorbidities when testing the association between albumin and dehiscence.
The patient cohort included 268 individuals; of whom, 154 were men. The average age of the patients at surgery was 63 years. When controlling for all other variables, albumin was the only statistically significant predictor of postoperative dehiscence, P = .005. Patients with albumin of 3.5 to 3.9 g/dL had 3.24 times higher odds of dehiscence (95% confidence interval 1.42 to 7.38) in comparison with participants in the 4+ g/dL group. There was no difference of odds between the 3.0 to 3.4 group and the 4+ reference group.
Our study demonstrated that among those individuals meeting the inclusion criteria, there is a statistically significant association between lower albumin levels and postoperative complication rates, specifically dehiscence.
在诊断出癌症的个体中,营养不足很常见。本研究评估了术前白蛋白与经切除术主要治疗的新诊断为口腔鳞状细胞癌的健康患者术后并发症之间的关联。
对 2005 年至 2019 年间新诊断为口腔鳞状细胞癌的患者进行回顾性队列研究。研究纳入了仅由一位外科医生(ERC)转诊和管理且在术前未接受任何营养支持的患者。主要预测变量为术前白蛋白水平。其他研究变量包括患者的人口统计学数据和 TNM 分期。与原发性消融手术相关的并发症是主要的结局变量。采用 χ²检验评估 4+、3.5 至 3.9、3.0 至 3.4g/dL 三个独立的白蛋白组与术后并发症之间的显著相关性。当检验白蛋白与裂开之间的关联时,采用多变量逻辑回归分析来控制临床变量和合并症。
患者队列包括 268 名患者,其中 154 名是男性。手术时患者的平均年龄为 63 岁。在控制所有其他变量的情况下,白蛋白是术后裂开的唯一具有统计学意义的预测因子,P=0.005。白蛋白水平为 3.5 至 3.9g/dL 的患者发生裂开的可能性是白蛋白水平为 4+g/dL 组的 3.24 倍(95%置信区间 1.42 至 7.38)。白蛋白水平为 3.0 至 3.4g/dL 的患者与白蛋白水平为 4+g/dL 的参考组相比,裂开的可能性没有差异。
我们的研究表明,在符合纳入标准的个体中,较低的白蛋白水平与术后并发症发生率(特别是裂开)之间存在统计学显著关联。